Infectious Diseases and Rare Diseases

Emerging Technologies Involved in HIV/AIDS

Increasing infectious diseases pose a grave threat based on their impact on global health, agriculture and on the economy. Emerging infections in animals can be reduced by using the advanced HIV vaccines that can effectively safeguard animal health and stop the transmission of zoonotic diseases to human beings. The HIV vaccine market is expected to reach $57,885.4 million by 2019. Major factors behind the growth of vaccine technology market include increasing enthusiasm in the government to expand immunization across the globe thereby increasing investments from respective companies in vaccine development, and increasing initiatives by the non-government organizations towards HIV/AIDS. The HIV/STD surveillance system in Texas presently uses the HIV/AIDS Reporting System also known as HARS in order to monitor the epidemic in Texas and then report the required data to CDC in order to monitor the epidemic nationally. eHARS provides significant advantage over HARS in terms of storing and processing information. The current HIV testing includes antibody test and HIV diagnosis. Over the past decade, EIA tests have seen major improvements in performance and accuracy and also there is introduction of rapid tests. With the expansion in specimen types options for testing programs have also increased.